ROIV
Roivant Sciences Ltd. · Healthcare
Director Daniel Allen Gold sold $39.1M of Roivant Sciences Ltd.
Sold$39,065,213
$23.05Price
1,694,614Shares
−9%Stake
What ROIV did after the filing
- The stock from Fri, Dec 19 open, $21.83
- −0.8%
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Feb 4 close.
Traded Tue, Dec 16. Filed Thu, Dec 18, 7:54 PM ET, after the close. Returns use the Dec 19 open and the Feb 4 close. Not investment advice.